Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

This purpose of this study is to determine if the herbal compound, Blue Citrus, decreases joint and bone pain associated with Aromotase Inhibitor therapy (AIT).

Another purpose of the study is to find out if Blue Citrus improves how you feel while taking AIT and if your quality of life improves.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Legacy Health System
• Treatments: Aromatase Inhibitors

Criteria

Inclusion Criteria:

1. Post Menopausal - evidenced by no menses for the past 6 months or FSH level >40

2. Patient complaints of musculoskeletal symptoms

3. Currently taking AIT for ER positive postmenopausal breast cancer

Exclusion Criteria:

1. Previously taken Blue Citrus

2. Presence of bone metastasis

3. Unable to complete VAS Pain Scale

4. Unable to comply/complete SF 12 Quality of Life survey

5. Plan to discontinue AIT in less then six months

6. Unable to complete ADL scale

7. Have diagnosis of fibromyalgia

8. Have diagnosis of rheumatoid arthritis